Wang N, Zheng L, Li M, Hou X, et al. Clinical efficacy and safety of individualized pembrolizumab administration based on pharmacokinetic in advanced non-small cell lung cancer: A prospective exploratory clinical trial. Lung Cancer 2023;178:183-190.
PMID: 36868179